• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: TERUMO BCT SPECTRA OPTIA; SPECTRA OPTIA EXCHANGE SET

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

TERUMO BCT SPECTRA OPTIA; SPECTRA OPTIA EXCHANGE SET Back to Search Results
Catalog Number 4122201
Device Problems Use of Device Problem (1670); Insufficient Information (3190)
Patient Problem Air Embolism (1697)
Event Date 06/24/2023
Event Type  Injury  
Manufacturer Narrative
Investigation: a disposable complaint history search was performed for this lot and found no reports for similar issues on this lot.Correction: internal retraining was completed on (b)(6) 2023.A message was sent to all staff at the customer organization which included informing them of the error in the setup of the optia machine which resulted in the patient receiving air into their vein, the potential impact if more air had entered the patient circulatory system, asking them to double check that the optia machine¿s tubes and blood warmer¿s set are fully primed before commencing treatment, and that there is no alarm on the blood warming device to alert them of air within the tube, so requires manual checks.Investigation is in process, a follow-up report will be provided.
 
Event Description
The customer reported that during a procedure on a spectra optia the patient seemed to be unwell.The operator then noticed they had not primed the astotherm blood warmer tubing.The operator paused and then ended the procedure.The patient recovered after high flow oxygen was administered.According to the customer it was clear the patient did receive an amount of air from the unprimed tubing line, however, it is unknown how much the patient received.The customer said all luer connections were tight and there was no clotting in the channel or in the return reservoir.The patient is in stable condition.Patient id is unknown at this time.The collection set is not available for return because it was discarded by the customer.
 
Event Description
The customer reported that during a procedure on a spectra optia the patient seemed to be unwell.The operator then noticed they had not primed the astotherm blood warmer tubing.The operator paused and then ended the procedure.The patient recovered after high flow oxygen was administered.According to the customer it was clear the patient did receive an amount of air from the unprimed tubing line, however, it is unknown how much the patient received.The customer said all luer connections were tight and there was no clotting in the channel or in the return reservoir.The patient is in stable condition.The collection set is not available for return because it was discarded by the customer.
 
Manufacturer Narrative
This report is being filed to provide additional information in a.1, h.6 and h.10.Investigation: a disposable complaint history search was performed for this lot and found no reports for similar issues on this lot.A review of the device history record (dhr) for this unit showed no irregularities during manufacturing that were relevant to this issue.In this incident, two tas nurses were involved; the first nurse prepared the optia machine ready for use and the second nurse initiated the treatment.The first nurse prepared the machine including priming the tubes connected to the machine.However, a separate tube (blood warmer coil) that is separate from the machine kit but also needs to be attached to the machine to initiate the procedure.This tube was connected to the machine but was not primed by the nurse.There is an alarm in optia machine that alert staff of air in the tubes, but there is no alarm on the blood warming device to alert staff of air within the blood warmer coil.A second nurse attended to treat the patient, connected the patient to the machine and started the procedure without double checking that the blood warmer coil was indeed primed.The customer said all luer connections were tight and there was no clotting in the channel or in the return reservoir.Correction: internal retraining was completed on 29 june 2023.A message was sent to all staff at the customer organization which included informing them of the error in the setup of the optia machine which resulted in the patient receiving air into their vein, the potential impact if more air had entered the patient circulatory system, asking them to double check that the optia machine's tubes and blood warmer's set are fully primed before commencing treatment, and that there is no alarm on the blood warming device to alert them of air within the tube, so requires manual checks.Investigation is in process, a follow-up report will be provided.
 
Event Description
An adult patient attended a therapeutic apheresis services (tas) units for red cell exchange (rce) procedure for the treatment of sickle cell disorder.Prior to the procedure the optia machine is usually prepared ready for use including priming the tubes used for the rce.The customer reported that during the procedure the patient seemed to be unwell.The operator then noticed they had not primed the astotherm blood warmer tubing.The operator paused and then ended the procedure.The patient recovered after medical intervention of high flow oxygen delivered to patient by two nurse specialists.The patient was transferred to a&e (accident and emergency) to be checked by a medical team and was discharged on the same evening.There was no further medical intervention following the high flow oxygen.A verbal report of the incident to the account manager noted that the patient did receive an amount of air from the unprimed tubing line but remained well.The customer said all luer connections were tight and there was no clotting in the channel or in the return reservoir.The collection set is not available for return because it was discarded by the customer.
 
Manufacturer Narrative
Investigation: a disposable complaint history search was performed for this lot and found no reports for similar issues on this lot.A review of the device history record (dhr) for this unit showed no irregularities during manufacturing that were relevant to this issue.In this incident, two tas nurses were involved; the first nurse prepared the optia machine ready for use and the second nurse initiated the treatment.The first nurse prepared the machine including priming the tubes connected to the machine.However, a separate tube (blood warmer coil) that is separate from the machine kit but also needs to be attached to the machine to initiate the procedure.This tube was connected to the machine but was not primed by the nurse.There is an alarm in optia machine that alert staff of air in the tubes, but there is no alarm on the blood warming device to alert staff of air within the blood warmer coil.A second nurse attended to treat the patient, connected the patient to the machine and started the procedure without double checking that the blood warmer coil was indeed primed.The customer said all luer connections were tight and there was no clotting in the channel or in the return reservoir.The run data file (rdf) was analyzed for this event.The reported incident stated that for the rbc exchange-depletion procedure, the blood warmer tubing located on the return line was inadvertently not primed prior to starting the run and some air may have been returned to the patient.Review of the run data file confirmed that the rbcx-d procedure was configured for blood warmer tubing on the return line with a 40ml volume.The appropriate alarm to ¿check connection from return line to blood warmer tubing¿ was generated immediately after the run was started.The procedure continued for 128 minutes until the operator ended the run with no patient rinseback.Analysis of the procedure showed that at 4 minutes into the run, the system accumulated return pump volume was 53 mls.This would be sufficient volume for the return pump to push the fluid in the optia return line (12mls) plus the contents of the blood warmer tubing (37.5mls) through the lines to the patient access.In the first 4 minutes, the pause button was pressed once, and 2 return pressure alarms occurred stopping the pumps for slightly over 1 minute in this timeframe.The optia system has two safety methods for detecting air in the set; the primary detection is the reservoir low-level sensor, and the secondary is the return line air detector (rlad) located on the outlet of the return pump.The blood warmer is attached to the end of the optia return line so located past both of these safety detection methods.There are warnings and instructions located in the spectra optia operator¿s manual and a screen that prompts the operator to prime the blood warmer tubing prior to patient connection.In addition, after the run is started, a prompt is generated to check that the blood warmer tubing is connected securely and at the correct height for proper operation.The terumo bct medical safety team concluded that, based on the clinical information provided, the spectra optia performed as intended, there were no suggested device failures, malfunctions, mislabeling, improper or inadequate design or manufacturing errors.However, there was a reported use error of the blood warmer tubing not being primed which contributed to or caused this adverse event.Correction: internal retraining was completed on (b)(6) 2023.A message was sent to all staff at the customer organization which included informing them of the error in the setup of the optia machine which resulted in the patient receiving air into their vein, the potential impact if more air had entered the patient circulatory system, asking them to double check that the optia machine¿s tubes and blood warmer¿s set are fully primed before commencing treatment, and that there is no alarm on the blood warming device to alert them of air within the tube, so requires manual checks.Root cause: a root cause assessment was performed for this complaint.The root cause was determined to be a user error where they did not prime the blood warmer tubing.
 
Manufacturer Narrative
This report is being filed to provide additional information in b.5, b.6 and h.10.Investigation: a disposable complaint history search was performed for this lot and found no reports for similar issues on this lot.A review of the device history record (dhr) for this unit showed no irregularities during manufacturing that were relevant to this issue.In this incident, two tas nurses were involved; the first nurse prepared the optia machine ready for use and the second nurse initiated the treatment.The first nurse prepared the machine including priming the tubes connected to the machine.However, a separate tube (blood warmer coil) that is separate from the machine kit but also needs to be attached to the machine to initiate the procedure.This tube was connected to the machine but was not primed by the nurse.There is an alarm in optia machine that alert staff of air in the tubes, but there is no alarm on the blood warming device to alert staff of air within the blood warmer coil.A second nurse attended to treat the patient, connected the patient to the machine and started the procedure without double checking that the blood warmer coil was indeed primed.The customer said all luer connections were tight and there was no clotting in the channel or in the return reservoir.The run data file (rdf) was analyzed for this event.The reported incident stated that for the rbc exchange-depletion procedure, the blood warmer tubing located on the return line was inadvertently not primed prior to starting the run and some air may have been returned to the patient.Review of the run data file confirmed that the rbcx-d procedure was configured for blood warmer tubing on the return line with a 40ml volume.The appropriate alarm to ¿check connection from return line to blood warmer tubing¿ was generated immediately after the run was started.The procedure continued for 128 minutes until the operator ended the run with no patient rinseback.Analysis of the procedure showed that at 4 minutes into the run, the system accumulated return pump volume was 53 mls.This would be sufficient volume for the return pump to push the fluid in the optia return line (12mls) plus the contents of the blood warmer tubing (37.5mls) through the lines to the patient access.In the first 4 minutes, the pause button was pressed once, and 2 return pressure alarms occurred stopping the pumps for slightly over 1 minute in this timeframe.The optia system has two safety methods for detecting air in the set; the primary detection is the reservoir low-level sensor, and the secondary is the return line air detector (rlad) located on the outlet of the return pump.The blood warmer is attached to the end of the optia return line so located past both of these safety detection methods.There are warnings and instructions located in the spectra optia operator¿s manual and a screen that prompts the operator to prime the blood warmer tubing prior to patient connection.In addition, after the run is started, a prompt is generated to check that the blood warmer tubing is connected securely and at the correct height for proper operation.The terumo bct medical safety team concluded that, based on the clinical information provided, the spectra optia performed as intended, there were no suggested device failures, malfunctions, mislabeling, improper or inadequate design or manufacturing errors.However, there was a reported use error of the blood warmer tubing not being primed which contributed to or caused this adverse event.Correction: internal retraining was completed on (b)(6) 2023.A message was sent to all staff at the customer organization which included informing them of the error in the setup of the optia machine which resulted in the patient receiving air into their vein, the potential impact if more air had entered the patient circulatory system, asking them to double check that the optia machine¿s tubes and blood warmer¿s set are fully primed before commencing treatment, and that there is no alarm on the blood warming device to alert them of air within the tube, so requires manual checks.Investigation is in process, a follow-up report will be provided.
 
Event Description
An adult patient attended a therapeutic apheresis services (tas) units for red cell exchange (rce) procedure for the treatment of sickle cell disorder.Prior to the procedure the optia machine is usually prepared ready for use including priming the tubes used for the rce.The customer reported that during the procedure the patient seemed to be unwell.The operator then noticed they had not primed the astotherm blood warmer tubing.The operator paused and then ended the procedure.The patient recovered after medical intervention of high flow oxygen delivered to patient by two nurse specialists.The patient was transferred to a&e (accident and emergency) to be checked by a medical team and was discharged on the same evening.There was no further medical intervention following the high flow oxygen.A verbal report of the incident to the account manager noted that the patient did receive an amount of air from the unprimed tubing line but remained well.The customer said all luer connections were tight and there was no clotting in the channel or in the return reservoir.The collection set is not available for return because it was discarded by the customer.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
SPECTRA OPTIA
Type of Device
SPECTRA OPTIA EXCHANGE SET
Manufacturer (Section D)
TERUMO BCT
lakewood CO 80215
Manufacturer (Section G)
TERUMO BCT
10810 w. collins ave
lakewood CO 80215
Manufacturer Contact
scot hilden
10810 w. collins ave
lakewood, CO 80215
MDR Report Key17459944
MDR Text Key320402029
Report Number1722028-2023-00269
Device Sequence Number1
Product Code LKN
Combination Product (y/n)N
Reporter Country CodeUK
PMA/PMN Number
K183081
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Health Professional
Reporter Occupation Nurse
Type of Report Initial,Followup,Followup,Followup
Report Date 08/04/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received08/04/2023
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Catalogue Number4122201
Device Lot Number2303143141
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received11/08/2023
Was Device Evaluated by Manufacturer? No
Date Device Manufactured03/14/2023
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Other;
Patient Age27 YR
Patient SexFemale
Patient Weight80 KG
-
-